BridgeBio Pharma, Inc. (BBIO)

SEC filing

BridgeBio Pharma, Inc.

BBIO · CIK 1743881

4 · Dec 16, 2025 · Kumar Neil sold 30.01K shares at $74.64/share ($2.2M); exercised options for 60.98K shares; reported 30.96K shares

Kumar Neil sold 30.01K shares at $74.64/share ($2.2M); exercised options for 60.98K shares; reported 30.96K shares

FORM 4

xslF345X05/wk-form4_1765927635.xmlSEC.gov

Graphics and non-inline formats (not embedded below).